Novel Biological and Pharmacological Interventions for Obesity Prevention

Novo Nordisk established the Transformational Prevention Unit (TPU) to develop scientifically valid and commercially scalable solutions to predict and pre-empt the risk of obesity and its consequences, so people can live healthier and longer lives. The TPU is committed to building novel, multi-sector partnerships that combine scientific, technological and implementation expertise across four inter-related product categories to deliver impactful solutions.

To achieve this, the TPU team at Novo Nordisk is seeking science data-backed opportunities to advance...